A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is an open-label, randomized feasibility trial in which patients admitted to Oregon Health \& Science University (OHSU) after a pregnancy complicated by preeclampsia who are considering a progestin-only pill contraception postpartum will be randomized to norethindrone or drospirenone for 6 weeks following hospital discharge.
Epistemonikos ID: 894718e143f55802816e050331f71412f151f8c3
First added on: Dec 20, 2025